247. Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
作者: Rebecca Smith-Bindman.;Susan A Alber.;Marilyn L Kwan.;Priscila Pequeno.;Wesley E Bolch.;Erin J A Bowles.;Robert T Greenlee.;Natasha K Stout.;Sheila Weinmann.;Lisa M Moy.;Carly Stewart.;Melanie Francisco.;Cameron Kofler.;James R Duncan.;Jonathan Ducore.;Malini Mahendra.;Jason D Pole.;Diana L Miglioretti.
来源: N Engl J Med. 2025年393卷13期1269-1278页
Assessing the risk of radiation-induced hematologic cancer from medical imaging in children and adolescents might support informed decisions on the use of imaging.
248. Clesrovimab for Prevention of RSV Disease in Healthy Infants.
作者: Heather J Zar.;Eric A F Simões.;Shabir A Madhi.;Octavio Ramilo.;Shelly D Senders.;Julie S Shepard.;Kamolwish Laoprasopwattana.;Jorge Piedrahita.;Jose M Novoa.;Sergio L Vargas.;Marc Dionne.;Teresa Jackowska.;Enmei Liu.;Yasunori Ishihara.;Kazushige Ikeda.;Ying Zhang.;Radha A Railkar.;Jeannine Lutkiewicz.;Kalpit A Vora.;Xiaowei Zang.;Brian M Maas.;Andrew W Lee.;Andrea Guerra.;Anushua Sinha.; .
来源: N Engl J Med. 2025年393卷13期1292-1303页
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in healthy infants are needed.
|